EDIT
Price
$2.69
Change
-$0.04 (-1.47%)
Updated
Sep 18, 04:59 PM (EDT)
Capitalization
417.74M
52 days until earnings call
Intraday BUY SELL Signals
VRCA
Price
$4.65
Change
+$0.12 (+2.65%)
Updated
Sep 17 closing price
Capitalization
78.51M
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EDIT vs VRCA

EDIT vs VRCA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EDIT vs. VRCA commentary
Sep 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and VRCA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($418M) has a higher market cap than VRCA($78.5M). EDIT YTD gains are higher at: 32.683 vs. VRCA (-44.043). VRCA has higher annual earnings (EBITDA): -26.68M vs. EDIT (-67.46M). EDIT has more cash in the bank: 212M vs. VRCA (11.2M). VRCA has less debt than EDIT: VRCA (1.81M) vs EDIT (15.5M). EDIT has higher revenues than VRCA: EDIT (47M) vs VRCA (30.3M).
EDITVRCAEDIT / VRCA
Capitalization418M78.5M532%
EBITDA-67.46M-26.68M253%
Gain YTD32.683-44.043-74%
P/E RatioN/AN/A-
Revenue47M30.3M155%
Total Cash212M11.2M1,893%
Total Debt15.5M1.81M856%
FUNDAMENTALS RATINGS
EDIT vs VRCA: Fundamental Ratings
EDIT
VRCA
OUTLOOK RATING
1..100
3284
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5363
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (35) in the Biotechnology industry is in the same range as VRCA (62) in the Pharmaceuticals Major industry. This means that EDIT’s stock grew similarly to VRCA’s over the last 12 months.

EDIT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that EDIT’s stock grew similarly to VRCA’s over the last 12 months.

EDIT's SMR Rating (99) in the Biotechnology industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that EDIT’s stock grew similarly to VRCA’s over the last 12 months.

EDIT's Price Growth Rating (53) in the Biotechnology industry is in the same range as VRCA (63) in the Pharmaceuticals Major industry. This means that EDIT’s stock grew similarly to VRCA’s over the last 12 months.

EDIT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that EDIT’s stock grew similarly to VRCA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDITVRCA
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 22 days ago
87%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 18, 2026
Stock price -- (EDIT: $2.72 vs. VRCA: $4.65)
Brand notoriety: EDIT and VRCA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 166% vs. VRCA: 39%
Market capitalization -- EDIT: $417.74M vs. VRCA: $79.88M
EDIT [@Biotechnology] is valued at $417.74M. VRCA’s [@Biotechnology] market capitalization is $79.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.87B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green while VRCA’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • VRCA’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than VRCA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while VRCA’s TA Score has 2 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 6 bearish.
  • VRCA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than VRCA.

Price Growth

EDIT (@Biotechnology) experienced а +2.64% price change this week, while VRCA (@Biotechnology) price change was -6.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.04%. For the same industry, the average monthly price growth was -7.73%, and the average quarterly price growth was +7.51%.

Reported Earning Dates

EDIT is expected to report earnings on Nov 09, 2026.

VRCA is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-0.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
EDIT
Daily Signal:
Gain/Loss:
VRCA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFENX13.19N/A
N/A
Schwab Fundamental Emerging Mkts Eq Idx
NMIEX14.44N/A
N/A
Northern Active M International Equity
SVBAX31.77N/A
N/A
JHancock Balanced A
NESGX28.76N/A
N/A
Needham Small Cap Growth Retail
TANDX32.04N/A
N/A
Tandem Fund

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been closely correlated with BEAM. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if EDIT jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
+0.37%
BEAM - EDIT
66%
Closely correlated
+6.80%
CRBU - EDIT
65%
Loosely correlated
+4.80%
CRSP - EDIT
64%
Loosely correlated
+9.80%
PRME - EDIT
63%
Loosely correlated
+4.67%
VYGR - EDIT
60%
Loosely correlated
-0.33%
More